Large-scale genotyping identifies 41 new loci associated with breast cancer risk
By K. Michailidou, P. Hall, A. González-Neira, M. Ghoussaini, J. Dennis, R. Milne, M. Schmidt, J. Chang-Claude, S. Bojesen, M. Bolla and 209 more. Nature Genetics, 2013
1,135 citations recorded by the source corpus.
Breast cancer is the most common cancer among women. Common variants at 27 loci have been identified as associated with susceptibility to breast cancer, and these account for ∼9% of the familial risk of the disease. We report here a meta-analysis of 9 genome-wide association studies, including 10,052 breast cancer cases and 12,575 controls of European ancestry, from which we selected 29,807 SNPs for further genotyping. These SNPs were genotyped in 45,290 cases and 41,880 controls of European ancestry from 41 studies in the Breast Cancer Association Consortium (BCAC). The SNPs were genotyped as part of a collaborative genotyping experiment involving four consortia (Collaborative Oncological Gene-environment Study, COGS) and used a custom Illumina iSelect genotyping array, iCOGS, comprising more than 200,000 SNPs. We identified SNPs at 41 new breast cancer susceptibility loci at genome-wide significance (P < 5 × 10−8). Further analyses suggest that more than 1,000 additional loci are involved in breast cancer susceptibility.
Subfields: Genetics
View Paper: https://www.semanticscholar.org/paper/c0829a9eb50aead79ff8f8002ef6544dc0c98dd3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) (2016, background): “GWAS have identified reproducible genomic loci associated with many common human diseases, including cardiovascular disease (2), inflammatory bowel disease (3), type 2 diabetes (4) and breast cancer (5).”